---
$id: https://graph.org.ai/products/commodity/51111627
$type: Product
source: UNSPSC
code: "51111627"
title: "Doxifluridine"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Doxifluridine

**UNSPSC Code**: 51111627
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a pyrimidine antagonist with the molecular formula C9H11FN2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V1JK16Y2JP, chemically known as 1-((4s,2r,3r,5r)-3,4-dihydroxy-5-methyloxolan-2-yl)-5-fluoro-1,3-dihydropyrimidine-2,4-dione but generally known as doxifluridine, which bears US NIH Compound Identifier 18343. European Medicines Agency schedules Doxifluridine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06389MIG. The term DOXIFLURIDINE is an International Non-Proprietary Name. DOXIFLURIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule doxifluridine under HS 29349990 and SITC 51579. As of Q4 2014, DOXIFLURIDINE remains the US FDA Preferred Term for this commodity. Doxifluridine bears US NLM identifiers UMLS ID C0048808 and NCI Concept Code C978. SMILES: FC1CN(C2OC(C(O)C2O)C)C(=O)[NH]C1=O.

